• Guanabenz Acetate: Unveiling α2-Adrenergic Modulation in Ant

  2026-06-10

  Explore how Guanabenz Acetate, a selective α2-adrenergic receptor agonist, is advancing research at the intersection of GPCR signaling and antiviral innate immunity. This article reveals novel mechanistic insights and experimental strategies, bridging stress granule biology with viral pathogenesis.

• Methyl-β-cyclodextrin: Practical Guide for Membrane Choleste

  2026-06-10

  Methyl-β-cyclodextrin enables researchers to selectively extract cholesterol and modulate membrane fluidity in cell-based and biochemical assays. It is intended for research use in membrane studies and is not suitable for diagnostic or clinical applications. Proper attention to solubility, storage, and workflow parameters is critical to ensure reagent efficacy.

• HotStart Universal 2X FAST Green qPCR Master Mix: Precision

  2026-06-09

  HotStart Universal 2X FAST Green qPCR Master Mix (Rox) stands out for its rapid, inhibitor-tolerant amplification and seamless integration with all major qPCR instruments. Discover how this master mix empowers high-specificity gene expression analysis, informed by the latest advances in fruit abscission research and practical troubleshooting strategies.

• Deferasirox: Oral Iron Chelator for Advanced Research Workfl

  2026-06-09

  Deferasirox stands out as a versatile oral iron chelator for precision control of cellular iron metabolism in both iron overload and cancer models. This article translates recent mechanistic insights into actionable protocols for researchers, emphasizing troubleshooting strategies and the comparative advantages of APExBIO's Deferasirox in experimental design.

• Optimized hiPSC Platelet Differentiation: Small Molecule Adv

  2026-06-08

  This study presents a systematically optimized protocol for differentiating functional platelets from human induced pluripotent stem cells (hiPSCs). By refining embryoid body seeding, culture media, and supplementing with specific small molecules, the protocol achieves higher yields, reduced costs, and accelerated maturation, offering a scalable solution for platelet manufacturing and research.

• Network Medicine Identifies Apigenin for Alzheimer’s Therapy

  2026-06-08

  A recent network medicine study systematically identified apigenin (5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one) as a promising neuroprotective flavonoid for Alzheimer’s disease. Integrating computational analysis and in vitro validation, the research highlights apigenin’s modulation of apoptosis, inflammation, and microglial polarization—offering actionable targets for neurodegeneration models.

• THZ1: Covalent CDK7 Inhibitor Workflows for T-ALL Research

  2026-06-07

  THZ1, a covalent CDK7 inhibitor from APExBIO, empowers researchers to dissect transcriptional control and cell proliferation in T-ALL and beyond. This article unpacks robust protocols, advanced use-cases, and troubleshooting strategies tailored for high-fidelity cancer biology experiments.

• 5-(N,N-dimethyl)-Amiloride Hydrochloride in Endothelial Inju

  2026-06-06

  Explore how 5-(N,N-dimethyl)-Amiloride hydrochloride advances endothelial injury and sepsis research by uniquely integrating ion transport modulation with biomarker-driven assay design. Gain practical insights into its mechanistic applications and experimental protocols.

• Tofacitinib Citrate: Advanced Workflows in Immune Regulation

  2026-06-05

  Tofacitinib citrate (CP-690550 citrate) stands out as a precision tool for dissecting JAK-STAT-driven immune pathways and endothelial function under inflammatory stress. This guide translates current vascular research and validated protocols into actionable steps, troubleshooting, and comparative insights, empowering researchers to achieve reproducible and biologically relevant outcomes.

• Selective Inhibition of SARS-CoV-2 3CLpro by Merbromin: Mech

  2026-06-05

  Chen et al. identified merbromin as a selective, mixed-type inhibitor of the main protease (3CLpro) of SARS-CoV-2 through high-throughput screening. The study clarifies merbromin’s dual binding mechanism, specificity versus broad-spectrum serine proteases, and its implications for antiviral drug design.

• Bsa I (RNase-free): Technical Parameters for DNA Manipulatio

  2026-06-04

  Bsa I (RNase-free) provides precise DNA cleavage for molecular biology research, particularly in workflows where RNA integrity is essential. Its RNase-free formulation minimizes RNA degradation, making it suitable for sensitive gene cloning and DNA recombinant technology applications. This product is intended strictly for research purposes and is not appropriate for diagnostic or medical use.

• Dabigatran Etexilate: Clinical Advances as a Direct Thrombin

  2026-06-04

  This article reviews the innovation of dabigatran etexilate as the first oral direct thrombin inhibitor, emphasizing its pharmacological properties, efficacy in stroke and venous thromboembolism prevention, and advantages over traditional anticoagulants. We discuss the reference paper’s clinical insights, compare findings with internal resources, and outline protocol considerations for anticoagulant research.

• Honokiol: Applied Workflows for Advanced NF-κB Pathway Inhib

  2026-06-03

  Honokiol stands out as a robust small molecule for dissecting NF-κB-driven inflammatory and oxidative processes in cancer research. This guide provides actionable protocols, troubleshooting insights, and direct connections to recent advances in in vitro drug response analysis, ensuring maximized reproducibility and translational relevance.

• INO80 Chromatin Remodeller Enables DNA Damage Bypass via Gap

  2026-06-03

  The referenced study reveals that the INO80 chromatin remodeller is essential for postreplicative daughter-strand gap repair during DNA damage bypass. This work establishes INO80’s unique, H2A.Z-independent role in orchestrating nucleosome positioning to facilitate efficient access for DNA repair enzymes, with implications for genome stability and therapeutic research.

• EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1

  2026-06-02

  EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent designed to facilitate amide bond formation in peptide synthesis, bioconjugation, and nucleotide coupling workflows. It is intended strictly for in vitro laboratory applications, as there is no supporting data for in vivo or clinical use.

450 records 15/30 page Previous Next First page 上5页 1112131415 下5页 Last page